Home/Pipeline/Docetaxel Injection Non-Alcohol Formula

Docetaxel Injection Non-Alcohol Formula

Oncology (various cancers)

Approved/CommercialCommercial

Key Facts

Indication
Oncology (various cancers)
Phase
Approved/Commercial
Status
Commercial
Company

About Eagle Pharmaceuticals

Eagle Pharmaceuticals is a NASDAQ-listed company (EGRX) headquartered in Woodcliff Lake, NJ, dedicated to developing innovative drugs that result in meaningful improvements in patients' lives. The company operates with a strategic focus on critical care and oncology, balancing a commercial-stage portfolio with a pipeline of novel product candidates. Eagle's mission is to bring brilliant science to life by serving patients, healthcare providers, and health systems, thereby creating value for all stakeholders.

View full company profile

Therapeutic Areas

Other Oncology (various cancers) Drugs

DrugCompanyPhase
Bevacizumab BiosimilarAlembic PharmaceuticalsPhase 3